Click Video Iconto view the meeting.

Header

 

 

The Pawtucket City Council accepts email testimony for Public Input Period/Public Hearings at cityclerk@pawtucketri.com until 4:00 p.m. on the day of the meeting. 

Please type COUNCIL INPUT in the Subject box.

 

The public may also participate at Public Input Period/Public Hearings via videoconference:

Must join 10 minutes prior to meeting.

 

DIAL: 1-888-475-4499                                                          MEETING ID: 898 0417 7941

OR Join Online at www.Zoom.us - Click Join a Meeting –   PASSWORD:  CC25

OR  https://us06web.zoom.us/j/89804177941

           

AGENDA

 

 

TO:                  All Members of the Pawtucket City Council

                        Frank J. Milos, Jr., Esq., City Solicitor

                                                                                  

FROM:            Richard J. Goldstein, MMC, City Clerk

 

DATE:                                             September 4, 2025

 

SUBJECT:      COMMITTEE OF THE WHOLE

 

 

You are requested to attend a meeting of the City Council Committee of the Whole, to be held on Wednesday, September 10, 2025, at 6:20 p.m., at the Pawtucket Municipal Annex, 100 Freight Street, Second Floor – Room 204, Parking Lot Entrance at 75 Sabin Street, Pawtucket, Rhode Island.

 

The purpose of this meeting is for discussion and/or consideration of the following:

 

1.      PUBLIC INPUT PERIOD Must Sign-in at City Hall or Join via Zoom 10 minutes prior to meeting.

 

2.      Communication from Frank J. Milos, Jr., Esq., City Solicitor, to Richard J. Goldstein, MMC, City Clerk, (City of Pawtucket, Rhode Island vs. Amerisourcebergen Drug Corporation, et al.) (City Council Committee of the Whole Meeting of September 10, 2025)

A portion of this meeting may be held in Executive Session pursuant to § 42-46-4 and § 42-46-5 (A)(2) of the General Laws of the State of Rhode Island regarding pending litigation.

 

3.      EXECUTIVE SESSION:

 

City of Pawtucket, Rhode Island vs. Amerisourcebergen Drug Corporation, et al. (Case 1:18-cv-00139-WES-LDA) (Purdue Pharma/Sackler; Alvogen Inc.; Amneal Pharmaceuticals, Inc.; Apotex Inc.; Hikma Pharmaceuticals USA, Inc.; Indivior Inc.; Mylan Pharmaceuticals Inc.; Sun Pharmacuetical Industries, Inc.; and Zydus Pharmaceuticals, Inc.)

 

 

This meeting is being called by Council President Terrence E. Mercer.

Posted: September 4, 2025                                                                                                                                                               

This facility is accessible to people with disabilities.  Individuals needing assistance due to a disability or interpreter services for the deaf or hard of hearing must notify the City Clerk’s Office at (401) 728-0500 Ext. 225, 48 hours in advance of meeting date. TDD (401) 722-8239                                                                                                                                                                   

 (401) 728-0500 Ext 225   ● FAX (401) 728-8932

TDD (401) 722-8239

 

 

Published by ClerkBase
©2026 by Clerkbase. No Claim to Original Government Works.